Invictus BioPharma Holdings Ltd (IVBHL) is a clinical-phase drug development company developing novel pharmaceuticals based on two proprietary and patented delivery platforms for improving the bioavailability and efficacy of tocotrienols (a natural product which is one part of vitamin E)